Literature DB >> 1396759

Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

S P Borriello1, T Vale, J S Brazier, S Hyde, E Chippeck.   

Abstract

A new enzyme immunoassay (EIA) kit developed for the rapid detection of Clostridium difficile toxin A in faecal specimens, Premier (Meridian Diagnostics), was evaluated using 101 faecal specimens. Sixty-nine specimens were positive for Clostridium difficile by isolation of the organism and by cytotoxicity in tissue culture. The EIA for toxin A was positive in 49 of these 69 cases. No specimen that was negative for cytotoxicity was positive by EIA. Eight of the 32 specimens negative by both EIA and cytotoxicity assay yielded Clostridium difficile by culture. In five of these cases the cytotoxigenic status of the isolate was determined, and four were positive. There was no direct relationship between cytotoxin titre and EIA reading.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396759     DOI: 10.1007/bf01962079

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.

Authors:  S P Borriello; F E Barclay; P J Reed; A R Welch; J D Brown; D W Burdon
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

2.  Commercial latex test for Clostridium difficile toxin A does not detect toxin A.

Authors:  D M Lyerly; T D Wilkins
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

3.  Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.

Authors:  B E Laughon; R P Viscidi; S L Gdovin; R H Yolken; J G Bartlett
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

4.  Simplified procedure for the routine isolation of Clostridium difficile from faeces.

Authors:  S P Borriello; P Honour
Journal:  J Clin Pathol       Date:  1981-10       Impact factor: 3.411

5.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

6.  Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.

Authors:  S Kamiya; P J Reed; S P Borriello
Journal:  J Med Microbiol       Date:  1989-09       Impact factor: 2.472

7.  Enzyme immunoassay (ELISA) for detection of Clostridium difficile toxin B in specimens of faeces.

Authors:  V K Nguyen; B Rihn; C Heckel; F Bisseret; R Girardot; H Monteil
Journal:  J Med Microbiol       Date:  1990-04       Impact factor: 2.472

8.  Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.

Authors:  D M Lyerly; N M Sullivan; T D Wilkins
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

9.  Detection of Clostridium difficile toxins by enzyme immunoassay.

Authors:  C Krishnan
Journal:  J Hyg (Lond)       Date:  1986-02

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  12 in total

1.  The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces.

Authors:  J Freeman; M H Wilcox
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A.

Authors:  S O Vargas; D Horensky; A B Onderdonk
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

3.  Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.

Authors:  J L Staneck; L S Weckbach; S D Allen; J A Siders; P H Gilligan; G Coppitt; J A Kraft; D H Willis
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Evaluation of an oligonucleotide probe and an immunological test for direct detection of toxigenic Clostridium difficile in stool samples.

Authors:  G A Green; B Riot; H Monteil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

5.  Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins.

Authors:  S A Arrow; L Croese; R A Bowman; T V Riley
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

6.  Clostridium difficile is not associated with outbreaks of viral gastroenteritis in the elderly in the Netherlands.

Authors:  S Svraka; E Kuijper; E Duizer; D Bakker; M Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-27       Impact factor: 3.267

7.  Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime.

Authors:  E Chachaty; C Bourneix; S Renard; M Bonnay; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Authors:  C S Merz; C Kramer; M Forman; L Gluck; K Mills; K Senft; I Steiman; N Wallace; P Charache
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches.

Authors:  M J Alfa; T Du; G Beda
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.